Biotechnology Stocks II: Compare Returns of S&P 500 to Mineralys Therapeutics, Inc. (MLYS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and MLYS | ||
|---|---|---|
| S&P 500 | MLYS | |
| Start Date | Apr-01-2023 | Mar-31-2023 |
| Start Price | $2,800.75 | $15.66 |
| End Date | Apr-11-2025 | Apr-22-2025 |
| End Price | $5,363.36 | $13.21 |
| Number Monthly Prices | 26 | 26 |
| Min Date | Apr-01-2023 | Nov-30-2023 |
| Min Price | $4,284.52 | $6.66 |
| Max Date | Dec-01-2024 | Jun-30-2023 |
| Max Price | $6,010.09 | $17.05 |
| Total Return | 25.18% | -15.64% |
| Annualized Return | 10.92% | -7.55% |
| Current Value of $1,000 Purchase | $1,252 | $844 |
| Number Returns | 325 | 325 |
| Average Return | 13.80% | 3.68% |
| Minimum Return | -10.76% | -60.94% |
| Maximum Return | 40.27% | 138.44% |
| Number Profitable Returns | 293 | 141 |
| Percent Profitable Returns | 90.15% | 43.38% |
| Number Unprofitable Returns | 32 | 184 |
| Percent Unprofitable Returns | 9.85% | 56.62% |
| Profitable to Unprofitable Returns Ratio | 9.16 | 0.77 |
MLYS Performance Table and Chart
MLYS Dollar-cost Average
MLYS Trendline Chart
MLYS Moving Average Chart
MLYS Stock Return Map - See Patterns of Gains and Losses
MLYS Stock Returns/Purchase Dates